Baxter's Clinolipid wins FDA OK; addresses drug shortage
This article was originally published in Scrip
Executive Summary
Baxter won the US FDA's approval on 4 October to market its parenteral nutrition product Clinolipid (lipid injectable emulsion), which is intended for use in adults unable to eat or drink to provide a source of calories and essential fatty acids.